Literature DB >> 2420958

The effect of treatment on Actinobacillus actinomycetemcomitans in localized juvenile periodontitis.

R L Mandell, L S Tripodi, E Savitt, J M Goodson, S S Socransky.   

Abstract

Three treatment regimens including local tetracycline delivery, systemic doxycycline and surgery plus systemic doxycycline were investigated in a localized juvenile periodontitis (LJP) population. Of the investigated treatments only surgery plus systemic doxycycline for 14 days was effective in eliminating or suppressing Actinobacillus actinomycetemcomitans, an organism strongly associated with LJP lesions. While surgery plus antibiotics was the superior treatment, it appears that the possibility of reinfection or incomplete elimination of the organism exists. Careful long-term follow-up, including clinical and microbiological monitoring, is highly recommended in this periodontal population.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 2420958     DOI: 10.1902/jop.1986.57.2.94

Source DB:  PubMed          Journal:  J Periodontol        ISSN: 0022-3492            Impact factor:   6.993


  11 in total

1.  Improved, low-cost selective culture medium for Actinobacillus actinomycetemcomitans.

Authors:  M Alsina; E Olle; J Frias
Journal:  J Clin Microbiol       Date:  2001-02       Impact factor: 5.948

2.  Bacteriostatic and bactericidal in vitro activities of clarithromycin and erythromycin against periodontopathic Actinobacillus actinomycetemcomitans.

Authors:  R Piccolomini; G Catamo; G Di Bonaventura
Journal:  Antimicrob Agents Chemother       Date:  1998-11       Impact factor: 5.191

3.  The role of Actinobacillus actinomycetemcomitans in periodontal disease.

Authors:  J de Graaff; A J van Winkelhoff; R J Goené
Journal:  Infection       Date:  1989 Jul-Aug       Impact factor: 3.553

4.  Defining Genetic Fitness Determinants and Creating Genomic Resources for an Oral Pathogen.

Authors:  Ajay M Narayanan; Matthew M Ramsey; Apollo Stacy; Marvin Whiteley
Journal:  Appl Environ Microbiol       Date:  2017-06-30       Impact factor: 4.792

Review 5.  Periodontal disease as a specific, albeit chronic, infection: diagnosis and treatment.

Authors:  W J Loesche; N S Grossman
Journal:  Clin Microbiol Rev       Date:  2001-10       Impact factor: 26.132

6.  Diminished treatment response of periodontally diseased patients infected with the JP2 clone of Aggregatibacter (Actinobacillus) actinomycetemcomitans.

Authors:  Sheila Cavalca Cortelli; Fernando Oliveira Costa; Toshihisa Kawai; Davi Romeiro Aquino; Gilson Cesar Nobre Franco; Kazuhisa Ohara; Caio Vinícius Gonçalves Roman-Torres; José Roberto Cortelli
Journal:  J Clin Microbiol       Date:  2009-05-20       Impact factor: 5.948

7.  In vitro activity of azithromycin compared with that of erythromycin against Actinobacillus actinomycetemcomitans.

Authors:  R Pajukanta; S Asikainen; M Saarela; S Alaluusua; H Jousimies-Somer
Journal:  Antimicrob Agents Chemother       Date:  1992-06       Impact factor: 5.191

8.  Evaluation of the effect of probiotic (inersan®) alone, combination of probiotic with doxycycline and doxycycline alone on aggressive periodontitis - a clinical and microbiological study.

Authors:  Mishal Piyush Shah; Sheela Kumar Gujjari; Veerendrakumar Siddhpur Chandrasekhar
Journal:  J Clin Diagn Res       Date:  2013-03-01

9.  Receptor-Based Peptides for Inhibition of Leukotoxin Activity.

Authors:  Eric Krueger; Shannon Hayes; En Hyung Chang; Shailagne Yutuc; Angela C Brown
Journal:  ACS Infect Dis       Date:  2018-05-17       Impact factor: 5.084

10.  Antibiotic susceptibility of Aggregatibacter actinomycetemcomitans JP2 in a biofilm.

Authors:  Orit Oettinger-Barak; Stuart G Dashper; Deanne V Catmull; Geoffrey G Adams; Michael N Sela; Eli E Machtei; Eric C Reynolds
Journal:  J Oral Microbiol       Date:  2013-05-08       Impact factor: 5.474

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.